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Abstracts / International Journal of Surgery 12 (2014) S13eS117 S19no or mild pain in recovery. Similarly the patients who experiencedmild to
moderate pain on days 1, 2 and 3 was 86%, 92% and 93 % while severe pain
was 14% , 8% and 7% respectively. A signiﬁcant number of patients did not
require any additional pain relief 73% Vs 27% while only 4/36 reported of
nausea only. The overall patient satisfaction regarding pain control was
100%, which helped achieve a discharge of over 90% of patients by day 3.
Conclusions: The use of patient controlled wound soakers is a safe,
effective and reliable method of post-op pain control following breast
reconstruction.
*Median.
1187: RETROSPECTIVE ANALYSIS OF RE-EXCISION RATES IN BREAST
CANCER SURGERY
Michael Ding*,1, Roderick Prawiradiradja 2, Mark Yun 1, Ernest Chew4,
Habib Tafazal 3. 1Heart of England NHS Trust, Birmingham, UK; 2NHS,
London, UK; 3NHS, Birmingham, UK; 4University College London, London, UK.
Introduction: It is important to obtain sufﬁcient margins when per-
forming curative breast surgery. Surgery for re-excision is associated with
increased morbidity and postoperative complications. Our aim was to
evaluate the rate of re-excisions for inadequate margins in our unit.
Methods: A retrospective study was conducted on all surgeries performed
for breast cancer between 1/8/12 and 1/3/13 at a District General Hospital.
Data was obtained from histopathology and electronic patient records.
Results: 132 patients were included in the study. 77 WLE (Wide Local
Excision) and 55 mastectomies were performed with intraoperative
radiological margins assessment. 54.5% (n¼42) WLE were wire-guided.
The overall re-excision rate was 29.9% (n¼23). 23.8 % (n¼10) wire guided
procedures resulted in reexcision and 37.1% (n¼13) nonwire-guided un-
derwent re-excision. 7 WLE resulted in mastectomy. 34 patients had
margins of <2mm and 64.7% (n¼22) underwent re-excision.
Conclusions: Re-excision rates for breast conserving surgery remains high
despite intraoperative radiological margin assessment.
1361: LYMPHOSCINTIGRAM AND SENTINEL NODE BIOPSY: DOWE NEED
A PICTURE?
Somashree Chatterji*, Grit Dabritz. North Manchester General Hospital,
Manchester, UK.
Introduction: There is decreasing evidence supporting the use of lym-
phoscintigrams for sentinel node identiﬁcation in breast cancer. We aimed
to show if there was agreement between the number of nodes identiﬁed
pre-operatively on lymphoscintigram with that identiﬁed with dye or
gamma probe intraoperatively.
Methods: All patients of the lead consultant who had undergone a lym-
phoscintigram over a two-year period were identiﬁed using PACS. Images
and notes were analysed to compare pre- and intra-operative ﬁndings.
Results: 74 patients were identiﬁed, of which 93.2% (69) had lympho-
scintigrams identifying nodes. Of these, 18.9% (14) were positive on his-
tology. 48.6% (36) of patients who had nodes identiﬁed on
lymphoscintigram were found to have an equal number on histology.
28.4% (21) had fewer nodes identiﬁed pre-operatively than on histology,
while 23% (17) had more nodes identiﬁed pre-operatively than were
positive on histology. The false negative rate was 0.07%.
Conclusions: Our ﬁndings did not support use of routine lymphoscintig-
raphy. Current recommendations supports its use in previous axillary
surgery, and our rate of accurate correlation (48%) was poor compared
with blinded studies. The next stage would be to extend the scope of the
audit across the unit. A prospective, blinded study would better determine
causality.
1387: AN EVOLUTION IN THE SURGICAL MANAGEMENT OF PATIENTS
WITH SENTINEL LYMPH NODE METASTASES
Aisling Nic An Riogh*,1,2, Maeve McAllister 1,2, Michael J. Kerin 1,2,
Edel M. Quinn 1,2, Karl J. Sweeney 1,2. 1Division of Surgery, National
University of Ireland, University College Galway, Ireland; 2Breastcheck
Western Unit, Galway, Ireland.
Introduction: Until recently, detection of sentinel lymph node (SLN)
metastases mandated axillary clearance (AC) followed by adjuvant
chemotherapy. There is increasing evidence that this is no longer the
case. We aim to assess the impact of this evidence on our institution's
practice1.Methods: A retrospective cohort study of patients with SLN metastases
between January 2011-December 2012 was undertaken. Data was
collected from prospective databases, hospital records and pathology
reports.
During the study period, 103 patients had SLN metastases. The
decision regarding further management was made at multidisciplinary
meetings. 57 patients progressed to AC. Of these, 22 had chemotherapy
prior to completion AC. Nine of these patients had further axillary
metastases, of whom 3 showed partial/complete chemotherapy
response.
Results: There was no statistically signiﬁcant difference in treatment
duration between patients who had chemotherapy pre or post AC.
Nor was there any difference in the treatment duration of those
who required post-operative radiotherapy and those who didn't,
(p¼0.67 in the radiotherapy group, p¼0.95 in the no radiotherapy
group).
Conclusions: In conclusion, we have observed a radical change in the
management of patients with SLN metastases. There has been a move
away from immediate AC following the identiﬁcation of SLN metastases to
chemotherapy alone or combined with completion AC.
1401: SHOULDWE BE DOING OSNA INTRAOPERATIVE ASSESSMENT FOR
PATIENTS UNDERGOING MASTECTOMY FOR DCIS?
Mohammed Elniel*, Shamaela Waheed. The Royal Marsden Hospital,
London, UK.
Introduction: Invasive disease may be found at mastectomy for DCIS, a
sentinel node biopsy (SLNB) is usually performed. If the invasive focus in
the breast is small, sufﬁcient material may not be available for determi-
nation of receptor status. The sentinel node may be the only source of this
information, but this tissue is lost if the nodes are sent for intra-operative
assessment using one-step nucleic acid ampliﬁcation (OSNA). This study
examined OSNA results and treatment decisions in patients undergoing
mastectomy for DCIS.
Methods: Prospectively collected data was examined retrospectively in
patients who underwent mastectomy, SLNB and OSNA for DCIS, thought to
be without invasive disease, in a 12-month period.
Results: Of 53 patients, 38% had micro-invasive disease in the breast.
In 77% the node(s) were sent for OSNA. Micrometastasis was found
in 12% and macrometastasis in 7%, 1 patient had both. Of the OSNA
cases, frank invasive disease was found in 27% and microinvasive disease
in 7%.
Conclusions: When analysing sentinel nodes in patients undergoing
mastectomy for DCIS it may be prudent to send the node for formal his-
tology, not OSNA, so receptor status can be performed if micro-invasion is
found.
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0254: CORONARY ARTERY BYPASS GRAFTING WITHOUT A LEFT ANTE-
RIOR DESCENDING ARTERY GRAFT e IS IT WORTH IT?
Andrew McGuigan*, Rory Beattie, Alastair Graham. Department of Cardiac
Surgery, Royal Victoria Hospital, Belfast, UK.
Introduction: Revascularising the left anterior descending (LAD)
artery with a left internal mammary artery (LIMA) graft is often cited
as the advantage of surgery over stenting. Little is known about
patients undergoing coronary artery bypass grafting (CABG) without LAD
graft.
Methods: Retrospectively analysis of our unit's experience of CABG
without LAD graft was undertaken. Patients having concomitant pro-
cedures aside from CABG were excluded. The National Death Registry was
accessed for survival data.
Results: Full data was available on 91 patients, representing 2% and 25% of
our total CABG and redo CABG caseloads respectively. Mean logistic
EuroSCOREwas 5.9 and in-hospital mortality 3.2%, with O/Emortality 0.54.
Reasons for lack of LAD graft and outcomes: n (%) 5 year survival LAD not
graftable 56 (61.5%) 80.7% No obstructive LAD disease 23 (25.3%) 91.1%
Patient previous LIMA to LAD graft 11 (12.1%) 90.0%.
Conclusions: Two percent of patients undergoing isolated CABG did not
receive an LAD graft. Although the peri-operative mortality is acceptable,
patients with ungraftable LAD disease had a 5-year survival almost
